日前,日本鹿儿大学和北海道大学联合研究小组,共同研究开发了一种用于预测慢性粒细胞白血病急性化的基因诊断技术。这种技术的开发,比以往预测可能成为急性白血病的方法,提早一周以上,为此,它对于尽早实施有效措施,延续患者生命有着十分重要意义。而过去那些通过观察患者病情等综合性的判断方法,却多半治疗晚于发病而延误了时机。参加这项研究开发工作的杉村和久教授发现,在健康人和慢性粒细胞白血病患者中,淋巴细胞中通常不产生一种叫做精氨[基]琥珀酸酶-ASS(argininosuc- Recently, a joint research team of Japan’s Kagoshima University and Hokkaido University jointly researched and developed a genetic diagnostic technique for predicting the acuteness of chronic myeloid leukemia. The development of this technique is more than a week earlier than the prediction of possible acute leukemia. Therefore, it is of great significance to implement effective measures and prolong the life of patients as soon as possible. In the past, those who passed the observation of the patient’s condition and other comprehensive judgments, but most of the treatment delayed the timing later than the onset. To participate in the research and development work Cunningham and long Professor found that in healthy people and patients with chronic myeloid leukemia, lymphocytes usually do not produce a called argininosuccinic -ASS (argininosuc-